In November 2022 and in February 2023 the Anti-Doping Agency of Kenya (ADAK) reported two anti-doping rule violation against the Athlete Jarinter Mawia Mwasya after her samples first tested positive for the prohibited substance Erythropoietin (EPO) and thereupon tested positive for the prohitbited substance Testosterone and its metabolites.
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Kenya Sports Disputes Tribunal.
The Athlete accepted the test results and denied the intentional use of the substance. She alleged without any evidence that a that an unknown medication was injected by a doctor.
The Panel finds that the presence of multiple prohibited substances had been established in the Athlete's samples and accordingly that she committed and anti-doping rule violation. The Panel determines that she failed to demonstrate that the violations were not intentional.
Therefore the Panel decides on 31 August 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the decision.
